US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Revelation Biosciences, Inc.

2.85

-0.3100-9.81%

Volume:124.50K

Turnover:379.15K

Market Cap:2.58M

PE:-0.03

High:3.32

Open:3.21

Low:2.82

Close:3.16

Loading ...

Overview Company News Filings

Why Revelation Biosciences Inc. (REVB) Went Down On Thursday?

Top Premarket Decliners

MT Newswires Live

REVB Announces Positive Test Results

Zacks Small Cap Research

BRIEF-Gemini Priming Attenuates Inflammation In Human Peripheral Blood Mononuclear Cells

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

THOMSON REUTERS

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

REVB Starts 2025 With Bright Future Ahead

Zacks Small Cap Research

Revelation Biosciences Q4 EPS $(4.98)

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

BUZZ-Stephens lowers PT for Addus HomeCare amid Medicaid funding uncertainity

BRIEF-Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD Patients

Revelation doses first patient in PRIME Phase 1b clinical study

Revelation Biosciences Doses First Patient in Prime Phase 1B Clinical Study of Gemini in Ckd Patients

THOMSON REUTERS

Revelation Biosciences Inc - Top-Line Data Expected by Mid-Year

THOMSON REUTERS

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

BRIEF-Revelation Biosciences Says Regained Compliance With Nasdaq Minimum Bid Price Requirement

Revelation Biosciences Inc - on Feb 19, Regained Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS

Revelation Biosciences, Inc. Receives Continued Nasdaq Listing Approval

THOMSON REUTERS

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REVB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REVB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVB\",,,,,undefined,":{"symbol":"REVB","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":2.85,"timestamp":1745435988734,"preClose":3.16,"halted":0,"volume":124497,"delay":0,"floatShares":859183,"shares":905228,"eps":-87.68314,"marketStatus":"Trading","change":-0.31,"latestTime":"04-23 15:31:19 EDT","open":3.2052,"high":3.3223,"low":2.82,"amount":379150.21033020003,"amplitude":0.158956,"askPrice":2.89,"askSize":100,"bidPrice":2.8,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-87.68314,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745438400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.16,"postHourTrading":{"tag":"盘后","latestPrice":3.205,"preClose":3.205,"latestTime":"19:49 EDT","volume":202,"amount":630.65,"timestamp":1745365777137},"volumeRatio":1.911076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVB\",,,,,undefined,":{"symbol":"REVB","floatShares":859183,"roa":"-52.93%","roe":"-264.85%","lyrEps":-87.683143,"volumeRatio":1.911076,"shares":905228,"dividePrice":0,"high":3.3223,"amplitude":0.158956,"preClose":3.16,"low":2.82,"week52Low":2.36,"pbRate":"0.55","week52High":60.8,"institutionHeld":0,"latestPrice":2.85,"committee":0.818182,"eps":-87.68314,"divideRate":0,"volume":124497,"delay":0,"ttmEps":-87.68314,"open":3.2052,"prevYearClose":7.376,"prevWeekClose":3.08,"prevMonthClose":2.63,"prevQuarterClose":2.63,"fiveDayClose":3.05,"twentyDayClose":2.88,"sixtyDayClose":3.8144},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REVB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526562129","title":"Why Revelation Biosciences Inc. (REVB) Went Down On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526562129","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526562129?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:23","pubTimestamp":1744291422,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Revelation Biosciences Inc.  stands against other stocks that fall behind amid market optimism.Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the US will pause the imposition of higher tariffs on 75 countries for 90 days.In a post on Truth Social, Trump said that more than 75 countries have called to negotiate and have not retaliated in any way.“I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately,” he noted.Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.Despite the overall market optimism, 10 companies, predominantly in the biopharmaceutical sector, registered losses amid the lack of fresh developments to spar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-revelation-biosciences-inc-revb-132342916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","REVB","REVBW"],"gpt_icon":0},{"id":"2520425595","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2520425595","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520425595?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:42","pubTimestamp":1742211742,"startTime":"0","endTime":"0","summary":"CEA Industries (CEAD) shares dropped 29% pre-bell Monday after a 1.5% drop in the previous session.Gogo (GOGO) shares were down 27% after closing 0.2% lower Friday.Revelation Biosciences (REVB) stock was down 18% following a 4% increase in the previous session.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4132","REVB","CEAD","BK4086","GOGO","BK4139"],"gpt_icon":0},{"id":"2520579820","title":"REVB Announces Positive Test Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520579820","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520579820?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:05","pubTimestamp":1742209500,"startTime":"0","endTime":"0","summary":"Revelation Biosciences  is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has multiple product candidates in development that we believe have promising potential and are based on the biology of phosphorylated hexaacyl disaccharide  and its effect on the innate immune system. The impact of PHAD on the immune system has been studied over multiple years and has been shown to have a positive effect on the human immune system. The company’s current therapeutic candidates are all based on the active ingredient PHAD, which is a synthetic version of MPLA, that is known to stimulate TLR-4. PHAD stimulation of TLR-4 leads to the production of multiple types of cytokines and chemokines which modulate the activity of the innate and adaptive immune response. Modulated activities may include stimulation and recruitment of infection fighting immune cells, down-regulation of inflammation, and/or upregulation of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revb-announces-positive-test-results-110500979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["REVBW","REVB","BK4139"],"gpt_icon":0},{"id":"2520510283","title":"BRIEF-Gemini Priming Attenuates Inflammation In Human Peripheral Blood Mononuclear Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2520510283","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520510283?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:12","pubTimestamp":1742206321,"startTime":"0","endTime":"0","summary":"BRIEF-Gemini Priming Attenuates Inflammation In Human Peripheral Blood Mononuclear CellsMarch 17 (Reuters) - Revelation Biosciences Inc REVB.O:GEMINI PRIMING ATTENUATES INFLAMMATION IN HUMAN PERIPHERA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3PX1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2520517923","title":"Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2520517923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520517923?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:04","pubTimestamp":1742205878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3PX1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2520129517","title":"Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2520129517","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520129517?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"– Observed response is excellent surrogate of the potential of Gemini in target indications –。In this study, human PBMCs were primed with either Gemini or placebo followed by challenge with clinically relevant promoter molecules of inflammation including high mobility box protein-1  and lipopolysaccharide  in vitro. HMGB-1 is an endogenous damage associated molecular pattern  that is generated during tissue injury  which drives the inflammatory response. LPS is an exogenous pathogen associated molecular pattern  that is generated from a bacterial infection and drives the inflammatory response associated with infection .\"These exciting results further demonstrate the game-changing potential of Gemini to attenuate the inflammatory response to clinically relevant DAMPS and PAMPS,\" said James Rolke, Chief Executive Officer of Revelation. \"We look forward to demonstrating the same protective effect in cells collected from CKD patients, which will be an excellent s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gemini-priming-attenuates-inflammation-human-100000120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","REVB","REVBW"],"gpt_icon":0},{"id":"2519889594","title":"Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2519889594","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519889594?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:00","pubTimestamp":1741860000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 13, 2025----Revelation Biosciences, Inc.  , a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced today that James Rolke Revelation’s Chief Executive Officer, will participate in a fireside chat at the 37th Annual Roth Conference on Tuesday, March 18, 2025 at 10:00 a.m. PT in Dana Point, CA.Investors who wish to schedule a meeting with Revelation’s management during the conference should contact their Roth representative.Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as a prevention for acute kidney injury, and for the treatment of chronic kidney disease.Company Contacts Mike PorterInvestor Relations Porter LeVay & Rose Inc.Email: mike@pl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revelation-biosciences-host-fireside-chat-100000585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4218","HST","REVB","BK4585","REVBW","BK4181","BK4588"],"gpt_icon":0},{"id":"2517772432","title":"REVB Starts 2025 With Bright Future Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517772432","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517772432?lang=en_us&edition=fundamental","pubTime":"2025-03-07 18:19","pubTimestamp":1741342740,"startTime":"0","endTime":"0","summary":"Revelation Biosciences  is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has multiple product candidates in development that we believe have promising potential and are based on the biology of phosphorylated hexaacyl disaccharide  and its effect on the innate immune system. The impact of PHAD on the immune system has been studied over multiple years and has been shown to have a positive effect on the human immune system. The company’s current therapeutic candidates are all based on the active ingredient PHAD, which is a synthetic version of MPLA, that is known to stimulate TLR-4. PHAD stimulation of TLR-4 leads to the production of multiple types of cytokines and chemokines which modulate the activity of the innate and adaptive immune response. Modulated activities may include stimulation and recruitment of infection fighting immune cells, down-regulation of inflammation, and/or upregulation of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revb-starts-2025-bright-future-101900815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["REVBW","REVB","BK4139"],"gpt_icon":0},{"id":"2517113058","title":"Revelation Biosciences Q4 EPS $(4.98)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113058","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113058?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:27","pubTimestamp":1741296456,"startTime":"0","endTime":"0","summary":"Revelation Biosciences Q4 EPS $(4.98)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44179962/revelation-biosciences-q4-eps-4-98","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB"],"gpt_icon":0},{"id":"2517113221","title":"Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113221","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113221?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:15","pubTimestamp":1741295700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 06, 2025----Revelation Biosciences, Inc.  , a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its three and twelve months ended December 31, 2024 financial results.Announced dosing of first patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients. Announced start of its PRIME Phase 1b Clinical Study of Gemini in CKD Patients. Received net proceeds of $3.7 million from the exercise of warrants in December 2024. Gemini is an intravenously administrated, proprietary formulation of phosphorylated hexaacyl disaccharide  that reduces the damage associated with inflammation by reprograming the innate immune system to respond to stress  in an attenuated manner. Revelation has conducted multiple preclinical studies demonstrating the therapeutic potential of Gemini in the target indications. Revelation previously announced positive Phase 1 clinical data for intravenous treatment with Gemini. The primar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revelation-biosciences-inc-announces-financial-211500476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","REVB","REVBW"],"gpt_icon":0},{"id":"2514837214","title":"BUZZ-Stephens lowers PT for Addus HomeCare amid Medicaid funding uncertainity","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514837214?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:15","pubTimestamp":1740575729,"startTime":"0","endTime":"0","summary":"BUZZ-Stephens lowers PT for Addus HomeCare amid Medicaid funding uncertainity** Brokerage Stephens cuts price target for home health services provider Addus HomeCare ADUS.O to $142 from $153; maintain","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL3N3PH0ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BN0W2W23.USD","ADUS","REVB","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4196"],"gpt_icon":0},{"id":"2514832581","title":"BRIEF-Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2514832581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514832581?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:51","pubTimestamp":1740574318,"startTime":"0","endTime":"0","summary":"BRIEF-Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD PatientsFeb 26 (Reuters) - Revelation Biosciences Inc REVB.O:REVELATION BIOSCIENCES DOSES FIRST PATIE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA6ZB538:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2514835837","title":"Revelation doses first patient in PRIME Phase 1b clinical study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514835837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514835837?lang=en_us&edition=fundamental","pubTime":"2025-02-26 19:21","pubTimestamp":1740568900,"startTime":"0","endTime":"0","summary":"Revelation Biosciences (REVB) announced dosing of the first patient in the PRIME, or PReconditioning IMmunostimulatory Evaluation, Phase 1b clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revelation-doses-first-patient-in-prime-phase-1b-clinical-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revelation-doses-first-patient-in-prime-phase-1b-clinical-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REVB"],"gpt_icon":0},{"id":"2514583865","title":"Revelation Biosciences Doses First Patient in Prime Phase 1B Clinical Study of Gemini in Ckd Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2514583865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514583865?lang=en_us&edition=fundamental","pubTime":"2025-02-26 19:00","pubTimestamp":1740567601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA6ZB538:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REVB"],"gpt_icon":0},{"id":"2514171838","title":"Revelation Biosciences Inc - Top-Line Data Expected by Mid-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2514171838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514171838?lang=en_us&edition=fundamental","pubTime":"2025-02-26 19:00","pubTimestamp":1740567601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA6ZB538:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REVB"],"gpt_icon":0},{"id":"2514838742","title":"Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838742","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514838742?lang=en_us&edition=fundamental","pubTime":"2025-02-26 19:00","pubTimestamp":1740567600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, February 26, 2025----Revelation Biosciences, Inc.  , a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced dosing of the first patient in the PRIME  Phase 1b clinical study of intravenous single ascending doses of Gemini in patients with Stage 3 and 4 Chronic Kidney Disease . The US-based, multi-site, placebo-controlled study will enroll up to forty patients in up to five cohorts.\"We are excited to announce the continued advancement of Gemini with the dosing of our first patient in the PRIME study,\" said James Rolke, Chief Executive Officer of Revelation. \"We look forward to a rapid enrollment and positive outcome of this study to bring Gemini one step closer to helping patients in need.\". Gemini is an intravenously administrated, proprietary formulation of phosphorylated hexaacyl disaccharide  that reduces the damage associated with inflammation by reprograming the innate immune system to respond to stress  in an at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revelation-biosciences-doses-first-patient-110000612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","REVB","REVBW"],"gpt_icon":0},{"id":"2514650704","title":"BRIEF-Revelation Biosciences Says Regained Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514650704","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514650704?lang=en_us&edition=fundamental","pubTime":"2025-02-25 06:16","pubTimestamp":1740435415,"startTime":"0","endTime":"0","summary":"BRIEF-Revelation Biosciences Says Regained Compliance With Nasdaq Minimum Bid Price RequirementFeb 24  - Revelation Biosciences Inc REVB.O:REVELATION BIOSCIENCES INC - ON FEB 19, REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTSource text: [ID:n0000950170-25-025626]Further company coverage: REVB.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2514070668","title":"Revelation Biosciences Inc - on Feb 19, Regained Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514070668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514070668?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:14","pubTimestamp":1740431674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2513231749","title":"Revelation Biosciences, Inc. Receives Continued Nasdaq Listing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2513231749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513231749?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:00","pubTimestamp":1740394801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA6SS07V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REVB","BK4139"],"gpt_icon":0},{"id":"2513174185","title":"Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2513174185","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513174185?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:00","pubTimestamp":1740394800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, February 24, 2025----Revelation Biosciences, Inc.  , a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced today the Nasdaq Stock Market LLC  formally notified the Company that REVB common stock will continue to be listed and traded on Nasdaq, as Revelation is in compliance with all requirements for continued listing.On January 21, 2025, Revelation announced the commencement of its PRIME  Phase 1b clinical study of escalating doses of intravenously administered Gemini in patients with Stage 3 and 4 Chronic Kidney Disease . The U.S. multi-site placebo-controlled study will enroll up to 40 patients in five cohorts of single escalating doses.Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revelation-biosciences-inc-receives-continued-110000141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","TSYW.SI","BK4588","USJW.SI","BK4112","MNQmain","TQQQ","REVBW","IE00B3QW5Z07.USD","QID",".IXIC","NQmain","NDAQ","BK4139","SQQQ","BK4585","QLD","LU2095319765.USD","LU2210150020.SGD","REVB","IE00BKPKM429.USD","PSQ","LU2210149790.SGD","USAW.SI","NVIW.SI"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REVB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"REVB","fiscalQuarterEnding":"2024/12","expectedEps":-3.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-4.98},{"market":"US","date":"2025-01-28","symbol":"REVB","defaultRemindTime":1738074600000,"type":"split","dateTimestamp":1738040400000,"forFactor":16,"toFactor":1,"ratio":16},{"market":"US","date":"2024-11-08","symbol":"REVB","fiscalQuarterEnding":"2024/09","expectedEps":-2.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2024-08-09","symbol":"REVB","fiscalQuarterEnding":"2024/06","expectedEps":-1.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-1.54},{"market":"US","date":"2024-05-10","symbol":"REVB","fiscalQuarterEnding":"2024/03","expectedEps":-5.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":-2.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REVB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REVB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1645156800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REVB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REVB","date":"2025-04-22","current":-0.189159,"percent":0.664516,"low":-37.206588,"twenty":-23.992356,"median":-0.454,"eighty":-0.083138,"high":5.503086,"avg":-6.744897,"sd":11.147718,"marketCap":2844678},"quantilePoints":[{"date":"2020-11-20","current":-23.987206,"twenty":-23.987206,"median":-23.987206,"eighty":-23.948043,"marketCap":91048069},{"date":"2020-11-27","current":-23.987206,"twenty":-23.987206,"median":-23.987206,"eighty":-23.987206,"marketCap":91048069},{"date":"2020-12-04","current":-24.231973,"twenty":-24.305403,"median":-23.987206,"eighty":-23.987206,"marketCap":91977130},{"date":"2020-12-11","current":-24.550171,"twenty":-24.452264,"median":-24.231973,"eighty":-23.987206,"marketCap":93184911},{"date":"2020-12-18","current":-24.686261,"twenty":-24.564857,"median":-24.354357,"eighty":-23.987206,"marketCap":93701469},{"date":"2020-12-24","current":-24.662274,"twenty":-24.681464,"median":-24.452264,"eighty":-23.987206,"marketCap":93610421},{"date":"2020-12-31","current":-24.599124,"twenty":-24.662274,"median":-24.452264,"eighty":-23.987206,"marketCap":93370723},{"date":"2021-01-08","current":-25.088659,"twenty":-24.843891,"median":-24.537933,"eighty":-23.987206,"marketCap":95228847},{"date":"2021-01-15","current":-24.966275,"twenty":-24.942043,"median":-24.571221,"eighty":-24.231973,"marketCap":94764316},{"date":"2021-01-22","current":-25.088659,"twenty":-24.962604,"median":-24.586886,"eighty":-24.231973,"marketCap":95228847},{"date":"2021-01-29","current":-24.770461,"twenty":-24.962604,"median":-24.674267,"eighty":-24.32988,"marketCap":94021067},{"date":"2021-02-05","current":-25.45581,"twenty":-25.044405,"median":-24.686261,"eighty":-24.354357,"marketCap":96622440},{"date":"2021-02-12","current":-25.162089,"twenty":-25.088659,"median":-24.794938,"eighty":-24.432683,"marketCap":95507566},{"date":"2021-02-19","current":-25.30895,"twenty":-25.162089,"median":-24.794938,"eighty":-24.452264,"marketCap":96065003},{"date":"2021-02-26","current":-25.088659,"twenty":-25.172761,"median":-24.843891,"eighty":-24.452264,"marketCap":95228847},{"date":"2021-03-05","current":-24.109589,"twenty":-25.162677,"median":-24.819415,"eighty":-24.413101,"marketCap":91512599},{"date":"2021-03-12","current":-24.623601,"twenty":-25.162089,"median":-24.794938,"eighty":-24.393519,"marketCap":93463630},{"date":"2021-03-19","current":-24.484818,"twenty":-25.162089,"median":-24.782699,"eighty":-24.40331,"marketCap":92936851},{"date":"2021-03-26","current":-24.599124,"twenty":-25.118031,"median":-24.686261,"eighty":-24.40331,"marketCap":93370723},{"date":"2021-04-01","current":-23.980372,"twenty":-25.088659,"median":-24.662274,"eighty":-24.354357,"marketCap":91022129},{"date":"2021-04-09","current":-24.136166,"twenty":-25.088659,"median":-24.599124,"eighty":-24.280927,"marketCap":91613477},{"date":"2021-04-16","current":-24.088229,"twenty":-25.088659,"median":-24.586886,"eighty":-24.136166,"marketCap":91431523},{"date":"2021-04-23","current":-23.965032,"twenty":-25.088659,"median":-24.572934,"eighty":-24.096773,"marketCap":90963903},{"date":"2021-04-30","current":-24.088229,"twenty":-25.078868,"median":-24.550171,"eighty":-24.088086,"marketCap":91431523},{"date":"2021-05-07","current":-23.968387,"twenty":-25.064182,"median":-24.480779,"eighty":-24.04988,"marketCap":90976640},{"date":"2021-05-14","current":-23.968387,"twenty":-25.054294,"median":-24.464502,"eighty":-24.023563,"marketCap":90976640},{"date":"2021-05-21","current":-23.968387,"twenty":-25.029768,"median":-24.452264,"eighty":-23.987206,"marketCap":90976640},{"date":"2021-05-28","current":-23.968387,"twenty":-24.995647,"median":-24.452264,"eighty":-23.987206,"marketCap":90976640},{"date":"2021-06-04","current":-23.992356,"twenty":-24.965541,"median":-24.427787,"eighty":-23.987206,"marketCap":91067617},{"date":"2021-06-11","current":-24.040293,"twenty":-24.962604,"median":-24.40331,"eighty":-23.987206,"marketCap":91249570},{"date":"2021-06-18","current":-24.088229,"twenty":-24.960891,"median":-24.354357,"eighty":-23.987206,"marketCap":91431523},{"date":"2021-06-25","current":-24.08799,"twenty":-24.951638,"median":-24.342118,"eighty":-23.987206,"marketCap":91430614},{"date":"2021-07-02","current":-23.992356,"twenty":-24.937099,"median":-24.280927,"eighty":-23.987206,"marketCap":91067617},{"date":"2021-07-09","current":-24.040293,"twenty":-24.917322,"median":-24.231973,"eighty":-23.987206,"marketCap":91249570},{"date":"2021-07-16","current":-23.992356,"twenty":-24.868368,"median":-24.136166,"eighty":-23.987206,"marketCap":91067617},{"date":"2021-07-23","current":-24.016324,"twenty":-24.868368,"median":-24.109589,"eighty":-23.987206,"marketCap":91158594},{"date":"2021-07-30","current":-23.993315,"twenty":-24.85613,"median":-24.088229,"eighty":-23.987206,"marketCap":91071256},{"date":"2021-08-06","current":-24.016324,"twenty":-24.843891,"median":-24.088229,"eighty":-23.987206,"marketCap":91158594},{"date":"2021-08-13","current":-24.016324,"twenty":-24.843891,"median":-24.088229,"eighty":-23.987206,"marketCap":91158594},{"date":"2021-08-20","current":-24.088229,"twenty":-24.794938,"median":-24.088229,"eighty":-23.992356,"marketCap":91431523},{"date":"2021-08-27","current":-24.088229,"twenty":-24.794938,"median":-24.088229,"eighty":-23.992356,"marketCap":91431523},{"date":"2021-09-03","current":-24.100214,"twenty":-24.794938,"median":-24.088229,"eighty":-23.992356,"marketCap":91477012},{"date":"2021-09-10","current":-24.138728,"twenty":-24.794938,"median":-24.088229,"eighty":-23.992356,"marketCap":91623201},{"date":"2021-09-17","current":-24.162723,"twenty":-24.775356,"median":-24.088229,"eighty":-23.992356,"marketCap":91714278},{"date":"2021-09-24","current":-24.186717,"twenty":-24.703101,"median":-24.088229,"eighty":-23.992356,"marketCap":91805354},{"date":"2021-10-01","current":-24.186717,"twenty":-24.686261,"median":-24.088229,"eighty":-23.992356,"marketCap":91805354},{"date":"2021-10-08","current":-24.186717,"twenty":-24.686261,"median":-24.109589,"eighty":-23.992356,"marketCap":91805354},{"date":"2021-10-15","current":-17.455668,"twenty":-24.667071,"median":-24.110893,"eighty":-23.992356,"marketCap":66256355},{"date":"2021-10-22","current":-17.421136,"twenty":-24.631336,"median":-24.088229,"eighty":-23.992356,"marketCap":66125284},{"date":"2021-10-29","current":-17.473106,"twenty":-24.604019,"median":-24.088229,"eighty":-23.987206,"marketCap":66322546},{"date":"2021-11-05","current":-17.490199,"twenty":-24.599124,"median":-24.088229,"eighty":-23.987206,"marketCap":66387426},{"date":"2021-11-12","current":-17.507465,"twenty":-24.599124,"median":-24.088229,"eighty":-23.968387,"marketCap":66452961},{"date":"2021-11-19","current":-17.490199,"twenty":-24.589334,"median":-24.088229,"eighty":-23.968387,"marketCap":66387426},{"date":"2021-11-26","current":-17.501249,"twenty":-24.579543,"median":-24.088229,"eighty":-23.968387,"marketCap":66429369},{"date":"2021-12-03","current":-17.611059,"twenty":-24.574647,"median":-24.08799,"eighty":-23.968387,"marketCap":66846174},{"date":"2021-12-10","current":-17.541996,"twenty":-24.572591,"median":-24.079361,"eighty":-23.968387,"marketCap":66584032},{"date":"2021-12-17","current":-6.041615,"twenty":-24.558591,"median":-24.064261,"eighty":-23.968387,"marketCap":66584032},{"date":"2021-12-23","current":-6.053508,"twenty":-24.550171,"median":-24.064261,"eighty":-23.952664,"marketCap":66715103},{"date":"2021-12-31","current":-6.065401,"twenty":-24.54038,"median":-24.052277,"eighty":-23.905351,"marketCap":66846174},{"date":"2022-01-07","current":-5.482647,"twenty":-24.509344,"median":-24.046285,"eighty":-17.579981,"marketCap":60423699},{"date":"2022-01-14","current":-8.104148,"twenty":-24.481587,"median":-24.040293,"eighty":-17.524731,"marketCap":89315000},{"date":"2022-01-21","current":-3.864151,"twenty":-24.47674,"median":-24.040293,"eighty":-17.524731,"marketCap":42586427},{"date":"2022-01-28","current":-3.20378,"twenty":-24.474292,"median":-24.040293,"eighty":-17.524731,"marketCap":35308538},{"date":"2022-02-04","current":-3.100432,"twenty":-24.462054,"median":-24.040293,"eighty":-17.509192,"marketCap":34169554},{"date":"2022-02-11","current":-2.738715,"twenty":-24.452264,"median":-24.039573,"eighty":-17.507465,"marketCap":30183106},{"date":"2022-02-18","current":-1.899015,"twenty":-24.452264,"median":-24.028308,"eighty":-17.490199,"marketCap":20928851},{"date":"2022-02-25","current":-1.808585,"twenty":-24.452264,"median":-24.016324,"eighty":-17.490199,"marketCap":19932239},{"date":"2022-03-04","current":-1.408113,"twenty":-24.452264,"median":-24.016324,"eighty":-17.472933,"marketCap":15518672},{"date":"2022-03-11","current":-1.498542,"twenty":-24.452264,"median":-24.016324,"eighty":-17.472933,"marketCap":16515284},{"date":"2022-03-18","current":-2.054036,"twenty":-24.427787,"median":-24.016324,"eighty":-17.438402,"marketCap":22637329},{"date":"2022-03-25","current":-3.332965,"twenty":-24.427787,"median":-24.016324,"eighty":-10.864256,"marketCap":36732270},{"date":"2022-04-01","current":-1.485624,"twenty":-24.40331,"median":-24.016324,"eighty":-8.104148,"marketCap":16372911},{"date":"2022-04-08","current":-1.408113,"twenty":-24.40331,"median":-24.016324,"eighty":-6.059454,"marketCap":15518672},{"date":"2022-04-14","current":-1.227254,"twenty":-24.40331,"median":-24.016324,"eighty":-6.053508,"marketCap":13525448},{"date":"2022-04-22","current":-1.40154,"twenty":-24.383728,"median":-23.998827,"eighty":-6.041615,"marketCap":16800030},{"date":"2022-04-29","current":-1.128358,"twenty":-24.359252,"median":-23.992356,"eighty":-5.690773,"marketCap":13525448},{"date":"2022-05-06","current":-0.962074,"twenty":-24.354357,"median":-23.992356,"eighty":-4.249392,"marketCap":11532224},{"date":"2022-05-13","current":-0.8452,"twenty":-24.354357,"median":-23.992356,"eighty":-3.353881,"marketCap":10131272},{"date":"2022-05-20","current":-0.534795,"twenty":-24.33542,"median":-23.989781,"eighty":-3.239951,"marketCap":8551913},{"date":"2022-05-27","current":-0.501877,"twenty":-24.330041,"median":-23.987206,"eighty":-3.124208,"marketCap":8025525},{"date":"2022-06-03","current":-0.455188,"twenty":-24.300508,"median":-23.987206,"eighty":-3.061677,"marketCap":7278929},{"date":"2022-06-10","current":-0.462168,"twenty":-24.280927,"median":-23.983789,"eighty":-2.89632,"marketCap":7390542},{"date":"2022-06-17","current":-0.42444,"twenty":-24.267592,"median":-23.968387,"eighty":-2.718045,"marketCap":6787232},{"date":"2022-06-24","current":-0.462168,"twenty":-24.249104,"median":-23.968387,"eighty":-2.211642,"marketCap":7390542},{"date":"2022-07-01","current":-0.980928,"twenty":-24.233613,"median":-23.968387,"eighty":-2.054036,"marketCap":15686049},{"date":"2022-07-08","current":-1.188432,"twenty":-24.231973,"median":-23.968387,"eighty":-1.914517,"marketCap":19004252},{"date":"2022-07-15","current":-1.263888,"twenty":-24.231032,"median":-23.968387,"eighty":-1.707822,"marketCap":20210871},{"date":"2022-07-22","current":-0.61308,"twenty":-24.226357,"median":-23.968387,"eighty":-1.604474,"marketCap":9803780},{"date":"2022-07-29","current":-0.531022,"twenty":-24.22031,"median":-23.968387,"eighty":-1.501126,"marketCap":8491582},{"date":"2022-08-05","current":-0.74051,"twenty":-24.210184,"median":-23.968387,"eighty":-1.423615,"marketCap":11841507},{"date":"2022-08-12","current":-0.734652,"twenty":-24.206201,"median":-23.968387,"eighty":-1.402855,"marketCap":11747843},{"date":"2022-08-19","current":-0.709522,"twenty":-24.196315,"median":-23.96671,"eighty":-1.28778,"marketCap":10895498},{"date":"2022-08-26","current":-0.634346,"twenty":-24.186717,"median":-23.938252,"eighty":-1.240982,"marketCap":9741086},{"date":"2022-09-02","current":-0.594699,"twenty":-24.186717,"median":-23.905351,"eighty":-1.205487,"marketCap":9132268},{"date":"2022-09-09","current":-0.631296,"twenty":-24.186717,"median":-20.750179,"eighty":-1.179,"marketCap":9694254},{"date":"2022-09-16","current":-0.57945,"twenty":-24.186717,"median":-17.559262,"eighty":-1.128121,"marketCap":8898107},{"date":"2022-09-23","current":-0.396466,"twenty":-24.186717,"median":-17.524731,"eighty":-1.08468,"marketCap":6088179},{"date":"2022-09-30","current":-0.397991,"twenty":-24.186717,"median":-17.524731,"eighty":-1.025856,"marketCap":6111595},{"date":"2022-10-07","current":-0.398601,"twenty":-24.178799,"median":-17.524731,"eighty":-0.951503,"marketCap":6120961},{"date":"2022-10-14","current":-0.366121,"twenty":-24.162723,"median":-17.524731,"eighty":-0.890809,"marketCap":5622198},{"date":"2022-10-21","current":-0.361242,"twenty":-24.162723,"median":-17.524645,"eighty":-0.807667,"marketCap":5547267},{"date":"2022-10-28","current":-0.475759,"twenty":-24.162723,"median":-17.507465,"eighty":-0.762435,"marketCap":7305814},{"date":"2022-11-04","current":-0.370086,"twenty":-24.162723,"median":-17.507465,"eighty":-0.745488,"marketCap":5683080},{"date":"2022-11-11","current":-0.379688,"twenty":-24.162723,"median":-17.507465,"eighty":-0.732163,"marketCap":5119091},{"date":"2022-11-18","current":-0.40151,"twenty":-24.138728,"median":-17.490199,"eighty":-0.718518,"marketCap":5413292},{"date":"2022-11-25","current":-0.362057,"twenty":-24.138728,"median":-17.490199,"eighty":-0.65301,"marketCap":4881377},{"date":"2022-12-02","current":-0.382481,"twenty":-24.138728,"median":-17.473106,"eighty":-0.639103,"marketCap":5156748},{"date":"2022-12-09","current":-0.342156,"twenty":-24.138728,"median":-17.472933,"eighty":-0.624861,"marketCap":4613065},{"date":"2022-12-16","current":-0.373229,"twenty":-24.138728,"median":-17.472933,"eighty":-0.609338,"marketCap":5032007},{"date":"2022-12-23","current":-0.313876,"twenty":-24.138728,"median":-17.464301,"eighty":-0.600646,"marketCap":4231782},{"date":"2022-12-30","current":-0.331856,"twenty":-24.138728,"median":-17.447035,"eighty":-0.59354,"marketCap":4474203},{"date":"2023-01-06","current":-0.37096,"twenty":-24.137703,"median":-17.438402,"eighty":-0.577387,"marketCap":5001411},{"date":"2023-01-13","current":-0.464529,"twenty":-24.136166,"median":-17.421136,"eighty":-0.532531,"marketCap":6262943},{"date":"2023-01-20","current":-0.424465,"twenty":-24.136166,"median":-9.995115,"eighty":-0.518517,"marketCap":5722791},{"date":"2023-01-27","current":-0.488794,"twenty":-24.133769,"median":-8.450629,"eighty":-0.495549,"marketCap":6590094},{"date":"2023-02-03","current":-0.45388,"twenty":-24.121785,"median":-6.065401,"eighty":-0.494972,"marketCap":6119367},{"date":"2023-02-10","current":-0.14215,"twenty":-24.112198,"median":-6.056481,"eighty":-0.484588,"marketCap":1916511},{"date":"2023-02-17","current":-0.655036,"twenty":-24.112198,"median":-6.053508,"eighty":-0.489542,"marketCap":8831428},{"date":"2023-02-24","current":-0.567874,"twenty":-24.112198,"median":-6.050059,"eighty":-0.492533,"marketCap":7656279},{"date":"2023-03-03","current":-0.573157,"twenty":-24.109589,"median":-6.041615,"eighty":-0.493011,"marketCap":7727500},{"date":"2023-03-10","current":-0.456941,"twenty":-24.100214,"median":-5.896061,"eighty":-0.492533,"marketCap":6160633},{"date":"2023-03-17","current":-0.37242,"twenty":-24.088229,"median":-5.491567,"eighty":-0.475759,"marketCap":5021094},{"date":"2023-03-24","current":-0.404115,"twenty":-24.088229,"median":-4.345702,"eighty":-0.466884,"marketCap":5448421},{"date":"2023-03-31","current":-0.427477,"twenty":-24.088229,"median":-3.391098,"eighty":-0.463866,"marketCap":4629378},{"date":"2023-04-06","current":-0.487449,"twenty":-24.088229,"median":-3.346037,"eighty":-0.462168,"marketCap":5278851},{"date":"2023-04-14","current":-0.424955,"twenty":-24.088229,"median":-3.253404,"eighty":-0.457997,"marketCap":4602075},{"date":"2023-04-21","current":-0.454119,"twenty":-24.088229,"median":-3.223158,"eighty":-0.456892,"marketCap":4917904},{"date":"2023-04-28","current":-0.445787,"twenty":-24.088229,"median":-3.124208,"eighty":-0.456396,"marketCap":4827667},{"date":"2023-05-05","current":-0.57309,"twenty":-24.088229,"median":-3.081055,"eighty":-0.456892,"marketCap":6206301},{"date":"2023-05-11","current":-0.604067,"twenty":-24.088229,"median":-3.055217,"eighty":-0.457733,"marketCap":6541777},{"date":"2023-05-19","current":-0.575823,"twenty":-24.088229,"median":-2.906655,"eighty":-0.458275,"marketCap":6235901},{"date":"2023-05-26","current":3.481025,"twenty":-24.088229,"median":-2.803307,"eighty":-0.456094,"marketCap":6774726},{"date":"2023-06-02","current":3.200989,"twenty":-24.088229,"median":-2.712878,"eighty":-0.453194,"marketCap":6229724},{"date":"2023-06-09","current":3.294542,"twenty":-24.088229,"median":-2.234895,"eighty":-0.449953,"marketCap":6411794},{"date":"2023-06-16","current":3.449944,"twenty":-24.088229,"median":-2.099251,"eighty":-0.444666,"marketCap":6714237},{"date":"2023-06-23","current":3.232381,"twenty":-24.088181,"median":-2.054036,"eighty":-0.439846,"marketCap":6290817},{"date":"2023-06-30","current":2.890494,"twenty":-24.08799,"median":-1.982985,"eighty":-0.434053,"marketCap":5625442},{"date":"2023-07-07","current":2.635633,"twenty":-24.08799,"median":-1.8538,"eighty":-0.430211,"marketCap":5129435},{"date":"2023-07-14","current":2.61139,"twenty":-24.08799,"median":-1.718156,"eighty":-0.427374,"marketCap":5082254},{"date":"2023-07-21","current":2.503541,"twenty":-24.081087,"median":-1.672941,"eighty":-0.424823,"marketCap":4872359},{"date":"2023-07-28","current":2.421488,"twenty":-24.075335,"median":-1.60189,"eighty":-0.4222,"marketCap":4712669},{"date":"2023-08-04","current":2.587769,"twenty":-24.066274,"median":-1.515887,"eighty":-0.417099,"marketCap":5036283},{"date":"2023-08-11","current":2.330419,"twenty":-24.064261,"median":-1.485624,"eighty":-0.414882,"marketCap":4535431},{"date":"2023-08-18","current":1.868375,"twenty":-24.064261,"median":-1.42749,"eighty":-0.406841,"marketCap":4358363},{"date":"2023-08-25","current":1.916697,"twenty":-24.064261,"median":-1.408113,"eighty":-0.40151,"marketCap":4471085},{"date":"2023-09-01","current":1.814383,"twenty":-24.064261,"median":-1.359612,"eighty":-0.399394,"marketCap":4232417},{"date":"2023-09-08","current":2.132663,"twenty":-24.057071,"median":-1.299352,"eighty":-0.396664,"marketCap":4974869},{"date":"2023-09-15","current":2.02468,"twenty":-24.052277,"median":-1.27332,"eighty":-0.386249,"marketCap":4722977},{"date":"2023-09-22","current":1.845698,"twenty":-24.052277,"median":-1.249572,"eighty":-0.382888,"marketCap":4305466},{"date":"2023-09-29","current":1.823562,"twenty":-24.045087,"median":-1.227254,"eighty":-0.379479,"marketCap":4253828},{"date":"2023-10-06","current":1.822482,"twenty":-24.040293,"median":-1.199868,"eighty":-0.373587,"marketCap":4251309},{"date":"2023-10-13","current":1.872424,"twenty":-24.040293,"median":-1.179,"eighty":-0.37234,"marketCap":4367809},{"date":"2023-10-20","current":1.545775,"twenty":-24.040293,"median":-1.130099,"eighty":-0.370985,"marketCap":3605835},{"date":"2023-10-27","current":1.590588,"twenty":-24.040293,"median":-1.128239,"eighty":-0.370087,"marketCap":3710370},{"date":"2023-11-03","current":1.601387,"twenty":-24.040293,"median":-1.122657,"eighty":-0.366683,"marketCap":3735560},{"date":"2023-11-10","current":1.573311,"twenty":-24.040293,"median":-1.079964,"eighty":-0.36485,"marketCap":3670068},{"date":"2023-11-17","current":4.864038,"twenty":-24.040293,"median":-1.046952,"eighty":-0.362004,"marketCap":4256340},{"date":"2023-11-24","current":4.821588,"twenty":-24.040293,"median":-0.980928,"eighty":-0.361756,"marketCap":4219193},{"date":"2023-12-01","current":5.203716,"twenty":-24.040293,"median":-0.952068,"eighty":-0.358157,"marketCap":4553579},{"date":"2023-12-08","current":3.958019,"twenty":-24.040293,"median":-0.893185,"eighty":-0.352002,"marketCap":3463516},{"date":"2023-12-15","current":4.001198,"twenty":-24.040293,"median":-0.868004,"eighty":-0.348624,"marketCap":3501300},{"date":"2023-12-22","current":4.101947,"twenty":-24.040101,"median":-0.809334,"eighty":-0.339511,"marketCap":3589462},{"date":"2023-12-29","current":3.813371,"twenty":-24.039669,"median":-0.802147,"eighty":-0.331811,"marketCap":3336940},{"date":"2024-01-05","current":3.662967,"twenty":-24.039094,"median":-0.795908,"eighty":-0.316145,"marketCap":3205327},{"date":"2024-01-12","current":3.370486,"twenty":-24.0343,"median":-0.761649,"eighty":-0.14215,"marketCap":2949388},{"date":"2024-01-19","current":3.085606,"twenty":-24.029506,"median":-0.756963,"eighty":1.560677,"marketCap":2700100},{"date":"2024-01-26","current":2.494762,"twenty":-24.021981,"median":-0.745488,"eighty":1.596636,"marketCap":2183074},{"date":"2024-02-02","current":0.762821,"twenty":-24.017139,"median":-0.736776,"eighty":1.626223,"marketCap":667516},{"date":"2024-02-09","current":0.666869,"twenty":-24.016324,"median":-0.729955,"eighty":1.620284,"marketCap":583552},{"date":"2024-02-16","current":1.167813,"twenty":-24.016324,"median":-0.722004,"eighty":1.605058,"marketCap":1021910},{"date":"2024-02-23","current":1.117544,"twenty":-24.016324,"median":-0.715831,"eighty":1.597824,"marketCap":977921},{"date":"2024-03-01","current":1.41143,"twenty":-24.016324,"median":-0.697297,"eighty":1.594085,"marketCap":1235090},{"date":"2024-03-08","current":1.314757,"twenty":-24.016324,"median":-0.657922,"eighty":1.591623,"marketCap":1150495},{"date":"2024-03-15","current":0.912596,"twenty":-24.016324,"median":-0.651424,"eighty":1.580222,"marketCap":798579},{"date":"2024-03-22","current":0.947398,"twenty":-24.016324,"median":-0.639911,"eighty":1.570396,"marketCap":829033},{"date":"2024-03-28","current":-32.997089,"twenty":-24.016324,"median":-0.6464,"eighty":1.564564,"marketCap":3968032},{"date":"2024-04-05","current":-36.935013,"twenty":-24.016324,"median":-0.655036,"eighty":1.55355,"marketCap":4441583},{"date":"2024-04-12","current":-31.503393,"twenty":-24.037176,"median":-0.696843,"eighty":1.492037,"marketCap":3788409},{"date":"2024-04-19","current":-30.417067,"twenty":-24.040293,"median":-0.713144,"eighty":1.409883,"marketCap":3657774},{"date":"2024-04-26","current":-29.057803,"twenty":-24.040293,"median":-0.722004,"eighty":1.375081,"marketCap":3494317},{"date":"2024-05-03","current":-31.910764,"twenty":-24.040293,"median":-0.729955,"eighty":1.323264,"marketCap":3837397},{"date":"2024-05-10","current":-29.873909,"twenty":-24.059467,"median":-0.736776,"eighty":1.317077,"marketCap":3592457},{"date":"2024-05-17","current":-0.338946,"twenty":-24.052277,"median":-0.729955,"eighty":1.314757,"marketCap":3037259},{"date":"2024-05-24","current":-0.348058,"twenty":-24.052277,"median":-0.722004,"eighty":1.30857,"marketCap":3118905},{"date":"2024-05-31","current":-0.300678,"twenty":-24.04988,"median":-0.715831,"eighty":1.286141,"marketCap":2694342},{"date":"2024-06-07","current":-0.402727,"twenty":-24.040293,"median":-0.697297,"eighty":1.231231,"marketCap":3608786},{"date":"2024-06-14","current":-0.411838,"twenty":-24.040293,"median":-0.660808,"eighty":1.22195,"marketCap":3690433},{"date":"2024-06-21","current":-0.391793,"twenty":-24.040293,"median":-0.653406,"eighty":1.218857,"marketCap":3510810},{"date":"2024-06-28","current":-0.338946,"twenty":-24.040293,"median":-0.651424,"eighty":1.215764,"marketCap":3037259},{"date":"2024-07-05","current":-0.320869,"twenty":-24.040293,"median":-0.640293,"eighty":1.206482,"marketCap":2875271},{"date":"2024-07-12","current":-0.328013,"twenty":-24.040293,"median":-0.635871,"eighty":1.167813,"marketCap":2939283},{"date":"2024-07-15","current":-0.329835,"twenty":-24.040293,"median":-0.634346,"eighty":1.166266,"marketCap":2955612},{"date":"2024-08-02","current":-0.269699,"twenty":-24.040293,"median":-0.632821,"eighty":1.16472,"marketCap":2416743},{"date":"2024-08-09","current":-0.191341,"twenty":-24.040293,"median":-0.61742,"eighty":1.16008,"marketCap":1714581},{"date":"2024-08-16","current":-0.092532,"twenty":-24.040293,"median":-0.61308,"eighty":1.16008,"marketCap":1471495},{"date":"2024-08-23","current":-0.129177,"twenty":-24.040293,"median":-0.606898,"eighty":1.143066,"marketCap":2054243},{"date":"2024-08-30","current":-0.104375,"twenty":-24.040293,"median":-0.603424,"eighty":1.108263,"marketCap":1659828},{"date":"2024-09-06","current":-0.091974,"twenty":-24.040293,"median":-0.600646,"eighty":1.092022,"marketCap":1462621},{"date":"2024-09-13","current":-0.094041,"twenty":-24.040245,"median":-0.598904,"eighty":1.081193,"marketCap":1495489},{"date":"2024-09-20","current":-0.088915,"twenty":-24.039861,"median":-0.594493,"eighty":1.074234,"marketCap":1413977},{"date":"2024-09-27","current":-0.086466,"twenty":-24.038135,"median":-0.591818,"eighty":1.070367,"marketCap":1375028},{"date":"2024-10-04","current":-0.084275,"twenty":-24.033102,"median":-0.589582,"eighty":1.054899,"marketCap":1340188},{"date":"2024-10-11","current":-0.082684,"twenty":-24.026726,"median":-0.583416,"eighty":0.993801,"marketCap":1314880},{"date":"2024-10-18","current":-0.08783,"twenty":-24.019584,"median":-0.580265,"eighty":0.945851,"marketCap":1396721},{"date":"2024-10-25","current":-0.086807,"twenty":-24.016324,"median":-0.575823,"eighty":0.938117,"marketCap":1380451},{"date":"2024-10-31","current":-0.088362,"twenty":-24.016324,"median":-0.573157,"eighty":0.931931,"marketCap":1405183},{"date":"2024-11-08","current":-0.08784,"twenty":-24.016324,"median":-0.567874,"eighty":0.924196,"marketCap":1396885},{"date":"2024-11-15","current":-0.088611,"twenty":-24.016324,"median":-0.565543,"eighty":0.912596,"marketCap":1374864},{"date":"2024-11-22","current":-0.208319,"twenty":-24.016324,"median":-0.556134,"eighty":0.88166,"marketCap":3232218},{"date":"2024-11-29","current":-0.210255,"twenty":-24.016324,"median":-0.539531,"eighty":0.790427,"marketCap":3262265},{"date":"2024-12-06","current":-0.125545,"twenty":-24.016324,"median":-0.531786,"eighty":0.763781,"marketCap":1947916},{"date":"2024-12-13","current":-0.114147,"twenty":-24.016324,"median":-0.525997,"eighty":0.736914,"marketCap":1771066},{"date":"2024-12-20","current":-0.087035,"twenty":-24.016324,"median":-0.518456,"eighty":0.679583,"marketCap":1350406},{"date":"2024-12-27","current":-0.097354,"twenty":-24.016324,"median":-0.516226,"eighty":0.640962,"marketCap":1510514},{"date":"2025-01-03","current":-0.18176,"twenty":-24.016324,"median":-0.507442,"eighty":0.621771,"marketCap":2820142},{"date":"2025-01-10","current":-0.160458,"twenty":-24.016324,"median":-0.504114,"eighty":0.480227,"marketCap":2489623},{"date":"2025-01-17","current":-0.11464,"twenty":-24.016324,"median":-0.497086,"eighty":-0.074844,"marketCap":1778728},{"date":"2025-01-24","current":-0.08922,"twenty":-24.016324,"median":-0.495528,"eighty":-0.076473,"marketCap":1384316},{"date":"2025-01-31","current":-0.128586,"twenty":-24.016324,"median":-0.493011,"eighty":-0.076473,"marketCap":1995109},{"date":"2025-02-07","current":-0.111186,"twenty":-24.016324,"median":-0.488121,"eighty":-0.078653,"marketCap":1725135},{"date":"2025-02-14","current":-0.108322,"twenty":-24.016324,"median":-0.483536,"eighty":-0.080371,"marketCap":1680694},{"date":"2025-02-21","current":-0.114571,"twenty":-24.016324,"median":-0.479116,"eighty":-0.08056,"marketCap":1777657},{"date":"2025-02-28","current":-0.092178,"twenty":-24.016324,"median":-0.473888,"eighty":-0.081411,"marketCap":1430206},{"date":"2025-03-07","current":-0.090095,"twenty":-24.016324,"median":-0.467506,"eighty":-0.081642,"marketCap":1397884},{"date":"2025-03-14","current":-0.196834,"twenty":-24.006737,"median":-0.466185,"eighty":-0.081684,"marketCap":2960095},{"date":"2025-03-21","current":-0.175164,"twenty":-23.99552,"median":-0.464526,"eighty":-0.082254,"marketCap":2634213},{"date":"2025-03-28","current":-0.166135,"twenty":-23.992548,"median":-0.462639,"eighty":-0.082626,"marketCap":2498429},{"date":"2025-04-04","current":-0.169145,"twenty":-23.992356,"median":-0.458285,"eighty":-0.083044,"marketCap":2543690},{"date":"2025-04-11","current":-0.181184,"twenty":-23.992356,"median":-0.456819,"eighty":-0.083134,"marketCap":2724736},{"date":"2025-04-17","current":-0.180582,"twenty":-23.992356,"median":-0.454653,"eighty":-0.083136,"marketCap":2715684},{"date":"2025-04-22","current":-0.189159,"twenty":-23.992356,"median":-0.454,"eighty":-0.083138,"marketCap":2844678}],"updateTime":1745398174037}}}